Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
References related to locations published in Clin. Infect. Dis.
| PMID | Journal | Published Date | Author | Title |
|---|---|---|---|---|
| 11340525 | Clin. Infect. Dis. | 2001 | Griffith DE et al. | Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. |
| 11360224 | Clin. Infect. Dis. | 2001 | Kaplan EL et al. | Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin). |
| 12145722 | Clin. Infect. Dis. | 2002 | Fry AM et al. | Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. |
| 12353204 | Clin. Infect. Dis. | 2002 | Adimora AA | Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. |
| 12746768 | Clin. Infect. Dis. | 2003 | Sánchez F et al. | Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? |
| 12684907 | Clin. Infect. Dis. | 2003 | Karlowsky JA et al. | Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). |
| 11073741 | Clin. Infect. Dis. | 2000 | Frenck RW et al. | Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. |
| 10987733 | Clin. Infect. Dis. | 2000 | Fogarty C et al. | Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. |
| 15095213 | Clin. Infect. Dis. | 2004 | Guchev IA et al. | Two regimens of azithromycin prophylaxis against community-acquired respiratory and skin/soft-tissue infections among military trainees. |
| 15909262 | Clin. Infect. Dis. | 2005 | Casey JR and Pichichero ME | Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis. |
| 17205439 | Clin. Infect. Dis. | 2007 | DuPont HL | Azithromycin for the self-treatment of traveler's diarrhea. |
| 22573850 | Clin. Infect. Dis. | 2012 | Buyck JM et al. | Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. |
| 23487375 | Clin. Infect. Dis. | 2013 | Coles CL et al. | Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment. |